Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease

被引：37

作者：

Hoppe, C ^{[1
]}

Vichinsky, E ^{[1
]}

Quirolo, K ^{[1
]}

Van Warmerdam, J ^{[1
]}

Allen, K ^{[1
]}

Styles, L ^{[1
]}

机构：

[1] Childrens Hosp, Dept Hematol Oncol, Oakland, CA 94609 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2000年 / 22卷 / 04期

关键词：

pediatric; sickle cell anemia; therapy;

D O I：

10.1097/00043426-200007000-00009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The efficacy and side effects of hydroxyurea in young children with sickle cell disease are unknown. The authors followed-up eight young children (mean age 3.7 years) during therapy with hydroxyurea for an average of 137 weeks. Total and fetal hemoglobin levels rose with hydroxyurea therapy. Hospital admission rates and total hospital days decreased during hydroxyurea therapy. No unexpected toxicity occurred, and growth and development were unaffected. This pilot study suggests that hydroxyurea is safe and effective in young children with sickle cell disease.

引用

页码：330 / 334

页数：5

共 18 条

[1] EFFECT OF HYDROXYUREA ON THE RHEOLOGICAL PROPERTIES OF SICKLE ERYTHROCYTES INVIVO [J].

BALLAS, SK ;

DOVER, GJ ;

CHARACHE, S .

AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (02) :104-111

[2]

CHARACHE S, 1994, AM J PEDIAT HEMATOL, V16, P62

[3] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[4] First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: Splenic regeneration [J].

Claster, S ;

Vichinsky, E .

BLOOD, 1996, 88 (06) :1951-1953

[5] Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial [J].

Ferster, A ;

Vermylen, C ;

Cornu, G ;

Buyse, M ;

Corazza, F ;

Devalck, C ;

Fondu, P ;

Toppet, M ;

Sariban, E .

BLOOD, 1996, 88 (06) :1960-1964

[6] Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia [J].

Jayabose, S ;

Tugal, O ;

Sandoval, C ;

Patel, P ;

Puder, D ;

Lin, T ;

Visintainer, P .

JOURNAL OF PEDIATRICS, 1996, 129 (04) :559-565

[7]

Kinney TR, 1999, BLOOD, V94, P1550

[8] HYDROXYUREA ENHANCES FETAL HEMOGLOBIN PRODUCTION IN SICKLE-CELL-ANEMIA [J].

PLATT, OS ;

ORKIN, SH ;

DOVER, G ;

BEARDSLEY, GP ;

MILLER, B ;

NATHAN, DG .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) :652-656

[9] MORTALITY IN SICKLE-CELL DISEASE - LIFE EXPECTANCY AND RISK-FACTORS FOR EARLY DEATH [J].

PLATT, OS ;

BRAMBILLA, DJ ;

ROSSE, WF ;

MILNER, PF ;

CASTRO, O ;

STEINBERG, MH ;

KLUG, PP .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) :1639-1644

[10]

RODGERS GP, 1992, SEMIN ONCOL, V19, P67

← 1 2 →